Context-Dependent Signaling Network of Ginsenoside Rg2: A Molecular Basis for Its Bidirectional Pharmacological...

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Molecular Biology

Background:

• Ginsenoside Rg2 (G-Rg2) is a key protopanaxatriol saponin from Panax ginseng with demonstrated neuroprotective, immunoregulatory, anti-inflammatory, and anti-tumor properties.
• Its diverse pharmacological effects stem from background-dependent regulation of intracellular signaling pathways, including AMPK, MAPK, NF-κB, and PI3K-AKT-mTOR.

Purpose of the Study:

• To review the mechanism-related research of Ginsenoside Rg2.
• To propose a network-based regulatory framework for G-Rg2.
• To offer suggestions for enhancing G-Rg2's bioavailability and targeting for clinical translation.

Main Methods:

• Literature review of existing mechanism-related research on G-Rg2.
• Analysis of metabolomics and multiomics studies in animal models.
• Examination of signaling pathway regulation (AMPK, MAPK, NF-κB, PI3K-AKT-mTOR).

Main Results:

• G-Rg2 exhibits bidirectional pharmacological properties, inducing apoptosis in cancer cells while promoting survival in ischemic conditions via the PI3K-AKT-mTOR pathway.
• G-Rg2 operates via a network-level regulatory mode, simultaneously modulating metabolic networks and signaling pathways.
• Challenges to G-Rg2's clinical translation include poor oral bioavailability, rapid clearance, isomer complexity, and limited safety data.

Conclusions:

• A network-based regulatory framework is proposed for G-Rg2.
• Strategies to enhance bioavailability and targeting are suggested to facilitate clinical translation.
• G-Rg2 holds potential for therapeutic applications if formulation and delivery challenges are addressed.